{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:24:35Z","timestamp":1793643875620,"version":"4.5.1"},"reference-count":259,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive malignancy with a persistently high mortality rate, largely attributable to therapy resistance and tumor recurrence. This review comprehensively explores the critical interplay between epigenetic dysregulation and the tumor microenvironment (TME) in driving OSCC progression. We detail how key epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs), intrinsically transform cancer cells and actively orchestrate pro-tumorigenic TME. These alterations substantially contribute to resistance against conventional therapies. Furthermore, we discuss the therapeutic potential of targeting these pathways using epigenetic drugs (epi-drugs), such as DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors, as well as engineered extracellular vesicles (EVs). The primary objective of this review is to synthesize current knowledge on the epigenetic-TME axis, thereby providing a mechanistic foundation for developing novel therapeutic strategies. We emphasize that rational combinations of epigenetic-targeting agents with conventional treatments or immunotherapy hold significant promise for overcoming drug resistance and improving clinical outcomes in OSCC patients.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1758433","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T07:19:49Z","timestamp":1769411989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment: mechanisms and therapeutics"],"prefix":"10.3389","volume":"17","author":[{"given":"Xuechao","family":"Li","sequence":"first","affiliation":[{"name":"School and Hospital of Stomatology, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Ren","sequence":"additional","affiliation":[{"name":"School and Hospital of Stomatology, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Pei","sequence":"additional","affiliation":[{"name":"School and Hospital of Stomatology, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale University School of Medicine","place":["New Haven, CT, United States"]},{"name":"Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale University","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Experimental Orofacial Medicine, Marburg University","place":["Marburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglin","family":"He","sequence":"additional","affiliation":[{"name":"China-Japan Union Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7632","article-title":"Patients with cT1N0M0 oral squamous cell carcinoma benefit from elective neck dissection: A SEER-based study","volume":"19","author":"Wushou","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","article-title":"Oral squamous cell carcinomas: state of the field and emerging directions","volume":"15","author":"Tan","year":"2023","journal-title":"Int J Oral Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13046-024-03163-z","article-title":"Areca nut-induced metabolic reprogramming and M2 differentiation promote OPMD Malignant transformation","volume":"43","author":"Yuan","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12567","article-title":"Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy","volume":"96","author":"Kinane","year":"2024","journal-title":"Periodontol 2000"},{"key":"B6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12916-024-03559-w","article-title":"Multispectral fluorescence imaging of EGFR and PD-L1 for precision detection of oral squamous cell carcinoma: a preclinical and clinical study","volume":"22","author":"Jin","year":"2024","journal-title":"BMC Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-23-1361","article-title":"A prospective double-blinded comparison of reflectance confocal microscopy with conventional histopathology for in vivo assessment in oral cancer","volume":"30","author":"Zanoni","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101930","article-title":"Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217482","article-title":"Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies","volume":"614","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"key":"B10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12943-024-02193-7","article-title":"Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy","volume":"23","author":"Gan","year":"2024","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102024","article-title":"Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41368-023-00267-8","article-title":"Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma","volume":"16","author":"Liu","year":"2024","journal-title":"Int J Oral Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/cancers15235600","article-title":"Epigenetic regulation in oral squamous cell carcinoma microenvironment: A comprehensive review","volume":"15","author":"Mesgari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13046-024-03141-5","article-title":"Connecting the dots: investigating the link between environmental, genetic, and epigenetic influences in metabolomic alterations in oral squamous cell carcinoma","volume":"43","author":"Gupta","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-024-01993-1","article-title":"DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.71519","article-title":"Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma","volume":"18","author":"Yang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102685","article-title":"BAP18 is involved in upregulation of CCND1\/2 transcription to promote cell growth in oral squamous cell carcinoma","volume":"53","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab280","article-title":"Histone sumoylation and chromatin dynamics","volume":"49","author":"Ryu","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mam.2019.04.002","article-title":"DNA methylation and chromatin modifiers in colorectal cancer","volume":"69","author":"Vymetalkova","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12943-021-01469-6","article-title":"LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway","volume":"20","author":"He","year":"2021","journal-title":"Mol Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41368-021-00115-7","article-title":"Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the lncRNA H19\/miR-675-5p\/PFKFB3 signaling pathway","volume":"13","author":"Yang","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10238-025-01903-9","article-title":"Cuproptosis in lung cancer: a nexus of ncRNA regulation, epigenetics, and tumor microenvironment Remodeling","volume":"26","author":"Imam","year":"2025","journal-title":"Clin Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-022-00824-z","article-title":"MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin\/FAK\/Src\/ERK\/\u03b2-catenin pathway","volume":"29","author":"Jang","year":"2022","journal-title":"J BioMed Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-023-02618-z","article-title":"Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling","volume":"42","author":"Huang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41368-025-00363-x","article-title":"Lysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression","volume":"17","author":"Chakraborty","year":"2025","journal-title":"Int J Oral Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12929-020-00644-z","article-title":"MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer","volume":"27","author":"Shiah","year":"2020","journal-title":"J BioMed Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.04.010","article-title":"Combined class I histone deacetylase and mTORC1\/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2","volume":"454","author":"Liang","year":"2019","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.11.057","article-title":"Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications","volume":"365","author":"Yang","year":"2024","journal-title":"J Control Release"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-025-00277-7","article-title":"Extracellular vesicles for the delivery of gene therapy","volume":"3","author":"Di Ianni","year":"2025","journal-title":"Nat Rev Bioengineering"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485174","article-title":"Tumor microenvironment in oral squamous cell carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/biom15050621","article-title":"Molecular mechanisms in the carcinogenesis of oral squamous cell carcinoma: A literature review","volume":"15","author":"Cabral","year":"2025","journal-title":"Biomolecules"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1585858","article-title":"Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment","volume":"16","author":"Qiao","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02781-9","article-title":"JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"B37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","article-title":"TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies","volume":"15","author":"Shi","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","article-title":"Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","article-title":"Cancer associated fibroblasts in cancer development and therapy","volume":"18","author":"Jia","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.ccell.2024.10.012","article-title":"Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma","volume":"42","author":"Huang","year":"2024","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2034","article-title":"Collagens in cancer: structural regulators and guardians of cancer progression","volume":"83","author":"De Martino","year":"2023","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","article-title":"Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology","volume":"40","author":"Spada","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4103\/ijpm.ijpm_512_21","article-title":"Elastin remodeling: Does it play a role in priming the Malignant phenotype of oral mucosa","volume":"66","author":"Prabhudesai","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tibtech.2020.06.003","article-title":"Extracellular matrix mimics using hyaluronan-based biomaterials","volume":"39","author":"Amorim","year":"2021","journal-title":"Trends Biotechnol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/ijmm.2025.5704","article-title":"Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review)","volume":"57","author":"Zheng","year":"2026","journal-title":"Int J Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12943-024-02183-9","article-title":"Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication","volume":"23","author":"Wang","year":"2024","journal-title":"Mol Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12951-023-02020-z","article-title":"HIF-1\u03b1 increases the osteogenic capacity of ADSCs by coupling angiogenesis and osteogenesis via the HIF-1\u03b1\/VEGF\/AKT\/mTOR signaling pathway","volume":"21","author":"Song","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0449-8","article-title":"A novel LncRNA HITT forms a regulatory loop with HIF-1\u03b1 to modulate angiogenesis and tumor growth","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ"},{"key":"B51","article-title":"Tumor angiogenesis as a prognostic factor in oral cavity carcinomas","volume":"20","author":"L\u00f3pez-Graniel","year":"2001","journal-title":"J Exp Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e2417708","DOI":"10.1002\/adma.202417708","article-title":"Personalized 3D vaccine integrates immunotherapy and antiangiogenic therapy to prevent oral squamous cell carcinoma recurrence","volume":"37","author":"Ren","year":"2025","journal-title":"Adv Mater"},{"key":"B53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","article-title":"Cell-cell communication: new insights and clinical implications","volume":"9","author":"Su","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00665-y","article-title":"Cancer-associated fibroblasts and its derived exosomes: a new perspective for reshaping the tumor microenvironment","volume":"29","author":"Peng","year":"2023","journal-title":"Mol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01318-0","article-title":"Tumor-derived exosomes in the regulation of macrophage polarization","volume":"69","author":"Baig","year":"2020","journal-title":"Inflammation Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12032-025-02774-6","article-title":"Exosomes in bridging macrophage-fibroblast polarity and cancer stemness","volume":"42","author":"Mortezaee","year":"2025","journal-title":"Med Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jitc-2023-007530","article-title":"New perspectives in cancer immunotherapy: targeting IL-6 cytokine family","volume":"11","author":"Soler","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.025","article-title":"Cancer epigenetics: Past, present and future","volume":"83","author":"Lee","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202307026","article-title":"Tunable DNMT1 degradation reveals DNMT1\/DNMT3B synergy in DNA methylation and genome organization","volume":"223","author":"Scelfo","year":"2024","journal-title":"J Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108640","article-title":"Therapeutic targeting of DNA methylation alterations in cancer","volume":"258","author":"Lee","year":"2024","journal-title":"Pharmacol Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.kint.2024.02.023","article-title":"Hypermethylation leads to the loss of HOXA5, resulting in JAG1 expression and NOTCH signaling contributing to kidney fibrosis","volume":"106","author":"Xiao","year":"2024","journal-title":"Kidney Int"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1016\/j.cell.2023.05.028","article-title":"DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs","volume":"186","author":"Guo","year":"2023","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103399","article-title":"DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs","volume":"164","author":"Flausino","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01633-x","article-title":"The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications","volume":"16","author":"Zhu","year":"2024","journal-title":"Clin Epigenetics"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-18-0124","article-title":"Calnexin impairs the antitumor immunity of CD4(+) and CD8(+) T cells","volume":"7","author":"Chen","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/gcc.22310","article-title":"Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma","volume":"55","author":"Clausen","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112919","article-title":"Integrative multi-omics analysis decodes HOXC9-driven Malignant transformation and metastasis in OSCC","volume":"28","author":"Xu","year":"2025","journal-title":"iScience"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v49i10.4698","article-title":"Methylation assessment of two DKK2 and DKK4 genes in oral squamous cell carcinoma patients","volume":"49","author":"Kheirandish","year":"2020","journal-title":"Iran J Public Health"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e18556","DOI":"10.1111\/jcmm.18556","article-title":"Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K\/AKT pathway in OLP-associated OSCC","volume":"28","author":"Liu","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms19061698","article-title":"Identification of differentially expressed genes induced by aberrant methylation in oral squamous cell carcinomas using integrated bioinformatic analysis","volume":"19","author":"Zhang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2020.01.050","article-title":"LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study","volume":"244","author":"Budania","year":"2020","journal-title":"Cancer Genet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0314-x","article-title":"Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India","volume":"9","author":"Basu","year":"2017","journal-title":"Clin Epigenetics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115559","article-title":"DNA methylation-based depiction of the immune microenvironment and immune-associated long non-coding RNAs in oral cavity squamous cell carcinomas","volume":"167","author":"Calanca","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.14715\/cmb\/2025.71.9.12","article-title":"Epigenetic and genetic events of oral squamous cell carcinoma: perspective on DNA methylation, silencing of tumor suppressor gene, and activating oncogenes","volume":"71","author":"Nizar Jawad","year":"2025","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13148-017-0386-7","article-title":"CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel","volume":"9","author":"Morandi","year":"2017","journal-title":"Clin Epigenetics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e0186873","DOI":"10.1371\/journal.pone.0186873","article-title":"Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13328","article-title":"Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient","volume":"51","author":"Sun","year":"2022","journal-title":"J Oral Pathol Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.identj.2024.09.035","article-title":"TPPP3, a good prognostic indicator, suppresses cell proliferation and migration in OSCC","volume":"75","author":"Xiao","year":"2025","journal-title":"Int Dent J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2021.105214","article-title":"Hypomethylation of lncRNA H19 as a potential prognostic biomarker for oral squamous cell carcinoma","volume":"129","author":"Lee","year":"2021","journal-title":"Arch Oral Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.01.020","article-title":"Epigenetic modulation of long noncoding RNA H19 in oral squamous cell carcinoma-A narrative review","volume":"9","author":"Rajendran","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737140.2025.2570164","article-title":"Epigenetic targeting in oral squamous cell carcinoma: mechanisms, therapies, and translational potential","volume":"26","author":"Yang","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"key":"B86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13148-019-0715-0","article-title":"Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC)","volume":"11","author":"Kim","year":"2019","journal-title":"Clin Epigenetics"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3290\/j.cjdr.a44747","article-title":"Immune landscape of the B7 and TNFR families in oral squamous cell carcinoma","volume":"23","author":"Ren","year":"2020","journal-title":"Chin J Dent Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/odi.15225","article-title":"Downregulation of PAX1 in OSCC enhances stemness and immunosuppression via IFIT1 and PD-L1 pathways","volume":"31","author":"Ko","year":"2025","journal-title":"Oral Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41598-022-05399-1","article-title":"Prognostic impact of miR-34b\/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas","volume":"12","author":"Supic","year":"2022","journal-title":"Sci Rep"},{"key":"B90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jnci\/djv303","article-title":"PDL1 Regulation by p53 via miR-34","volume":"108","author":"Cortez","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/mmr.2024.13421","article-title":"Epigenetic downregulation of the proapoptotic gene HOXA5 in oral squamous cell carcinoma","volume":"31","author":"Chen","year":"2025","journal-title":"Mol Med Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166428","article-title":"PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma","volume":"1868","author":"Bhol","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17071136","article-title":"Methylation-mediated silencing of miR-124\u20133 regulates LRRC1 expression and promotes oral cancer progression","volume":"17","author":"Liao","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2024.11.088","article-title":"Epigenetic regulation of HOXA3 and its impact on oral squamous cell carcinoma progression","volume":"139","author":"Padam","year":"2025","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.18502\/ajmb.v13i2.5523","article-title":"Methylation of TGM-3 promoter and its association with oral squamous cell carcinoma (OSCC)","volume":"13","author":"Shojaeian","year":"2021","journal-title":"Avicenna J Med Biotechnol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12672-024-00866-9","article-title":"Correlation of DNA methylation of DNMT3A and TET2 with oral squamous cell carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Discov Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.14670\/hh-18-327","article-title":"Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA","volume":"36","author":"Huang","year":"2021","journal-title":"Histol Histopathol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13115","article-title":"Histone modifications in oral squamous cell carcinoma and oral potentially Malignant disorders","volume":"26","author":"Yang","year":"2020","journal-title":"Oral Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1427725","article-title":"Histone modifications in head and neck squamous cell carcinoma","volume":"14","author":"Mao","year":"2024","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.064010","article-title":"Dysregulated PI3K\/AKT signaling in oral squamous cell carcinoma: The tumor microenvironment and epigenetic modifiers as key drivers","volume":"33","author":"Veerasamy","year":"2025","journal-title":"Oncol Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7150\/jca.103243","article-title":"Molecular insight into histone methylation as a novel target for oral squamous cell carcinoma: future hope in personalised medicine","volume":"16","author":"Rajendran","year":"2025","journal-title":"J Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/biom15010071","article-title":"Epigenetic regulation of stromal and immune cells and therapeutic targets in the tumor microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Biomolecules"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e5616","DOI":"10.1002\/bmc.5616","article-title":"Acidotic and hypoxic tumor microenvironment induces changes to histone acetylation and methylation in oral squamous cell carcinoma","volume":"37","author":"Khan","year":"2023","journal-title":"BioMed Chromatogr"},{"key":"B106","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/17501911.2024.2441652","article-title":"PX-12 modulates vorinostat-induced acetylation and methylation marks in CAL 27 cells","volume":"17","author":"Akhlaq","year":"2025","journal-title":"Epigenomics"},{"key":"B107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1620\/tjem.2023.J029","article-title":"Tumor promoting role of NRIP1 in oral squamous cell carcinoma: the involvement of NSD2-mediated histone methylation of DGCR8","volume":"260","author":"Zhang","year":"2023","journal-title":"Tohoku J Exp Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-022-01287-0","article-title":"KDM3A promotes oral squamous cell carcinoma cell proliferation and invasion via H3K9me2 demethylation-activated DCLK1","volume":"44","author":"Yang","year":"2022","journal-title":"Genes Genomics"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.identj.2024.01.011","article-title":"The significance of modified histone H3 in epithelial dysplasia and oral cancer","volume":"74","author":"Tachaveeraphong","year":"2024","journal-title":"Int Dent J"},{"key":"B110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.37796\/2211-8039.1391","article-title":"High levels of histone H3 K27 acetylation and tri-methylation are associated with shorter survival in oral squamous cell carcinoma patients","volume":"13","author":"Shahhosseini","year":"2023","journal-title":"Biomedicine (Taipei)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4616682","article-title":"Advances in the histone acetylation modification in the oral squamous cell carcinoma","volume":"2023","author":"Lu","year":"2023","journal-title":"J Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01786-3","article-title":"Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer","volume":"10","author":"Nunes","year":"2024","journal-title":"Cell Death Discov"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111921","article-title":"Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1\u03b2 and modulating immunosuppressive response in OSCC","volume":"132","author":"Mahale","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"20438","DOI":"10.1038\/s41598-021-99736-5","article-title":"DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes","volume":"11","author":"Hatanaka","year":"2021","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.06.002","article-title":"New mechanism of LncRNA: In addition to act as a ceRNA","volume":"9","author":"Zhang","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1123-y","article-title":"A novel IFN\u03b1-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma","volume":"19","author":"Ma","year":"2020","journal-title":"Mol Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/jop.70062","article-title":"Sex-related differences in histone acetylation and tumor development in a 4-nitroquinoline 1-oxide and ethanol-induced oral squamous cell carcinoma mouse model","volume":"54","author":"Naz\u00e1rio","year":"2025","journal-title":"J Oral Pathol Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00018-025-05765-y","article-title":"Preliminary investigation of the epigenetic regulation of KMT2D via H3K4me1\/H3K27ac in oral squamous cell carcinoma","volume":"82","author":"Yuan","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13148-024-01785-w","article-title":"Advances in the study of posttranslational modifications of histones in head and neck squamous cell carcinoma","volume":"16","author":"Xiao","year":"2024","journal-title":"Clin Epigenetics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-020-01154-0","article-title":"Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1002\/wrna.1754","article-title":"Noncoding RNAs in oral cancer","volume":"14","author":"Balakittnen","year":"2023","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-020-00521-9","article-title":"Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma","volume":"43","author":"Huang","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1532558","article-title":"Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications","volume":"16","author":"He","year":"2025","journal-title":"Front Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.01.046","article-title":"Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment","volume":"30","author":"Xu","year":"2022","journal-title":"Mol Ther"},{"key":"B125","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-biochem-062917-012708","article-title":"Long noncoding RNAs: molecular modalities to organismal functions","volume":"89","author":"Rinn","year":"2020","journal-title":"Annu Rev Biochem"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2020.07.001","article-title":"Mechanisms of long noncoding RNA nuclear retention","volume":"45","author":"Guo","year":"2020","journal-title":"Trends Biochem Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.616717","article-title":"Long noncoding RNAs in the metastasis of oral squamous cell carcinoma","volume":"10","author":"Xu","year":"2020","journal-title":"Front Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1716180","article-title":"Long non-coding RNAs as key orchestrators of the tumor microenvironment in lung cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: From disease code to drug role","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.86805","article-title":"Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK\/ERK signaling pathway via the miR-485-5p\/PAK4 axis","volume":"18","author":"Zhang","year":"2022","journal-title":"Arch Med Sci"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.657876","article-title":"Long non-coding RNA LINC01929 accelerates progression of oral squamous cell carcinoma by targeting the miR-137-3p\/FOXC1 axis","volume":"11","author":"Che","year":"2021","journal-title":"Front Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/cbm-191070","article-title":"LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375\/PAX6 axis","volume":"30","author":"Tong","year":"2021","journal-title":"Cancer biomark"},{"key":"B133","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12903-024-04388-2","article-title":"FOXD2-AS1 promotes Malignant cell behavior in oral squamous cell carcinoma via the miR-378 g\/CRABP2 axis","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Oral Health"},{"key":"B134","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13045-021-01179-y","article-title":"Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10142-024-01436-6","article-title":"Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma","volume":"24","author":"Wei","year":"2024","journal-title":"Funct Integr Genomics"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e2207549","DOI":"10.1002\/advs.202207549","article-title":"Yin yang 1-induced long noncoding RNA DUXAP9 drives the progression of oral squamous cell carcinoma by blocking CDK1-mediated EZH2 degradation","volume":"10","author":"Zhou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.110170","article-title":"The LINC00319 binding to STAT3 promotes the cell proliferation, migration, invasion and EMT process in oral squamous cell carcinoma","volume":"761","author":"Jiang","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1467151","article-title":"LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling","volume":"15","author":"Jiao","year":"2024","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms231810704","article-title":"An axis between the long non-coding RNA HOXA11-AS and NQOs enhances metastatic ability in oral squamous cell carcinoma","volume":"23","author":"Nakashima","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-022-05157-1","article-title":"lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S460730","article-title":"LncRNAs in immune and stromal cells remodel phenotype of cancer cell and tumor microenvironment","volume":"17","author":"Li","year":"2024","journal-title":"J Inflammation Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41419-023-06280-3","article-title":"PDPN(+) CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12935","article-title":"Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2\/GDF10 signaling in oral squamous cell carcinoma","volume":"16","author":"Zhang","year":"2022","journal-title":"Mol Oncol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5524231","article-title":"lncRNA DCST1-AS1 facilitates oral squamous cell carcinoma by promoting M2 macrophage polarization through activating NF-\u03baB signaling","volume":"2021","author":"Ai","year":"2021","journal-title":"J Immunol Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1830790","article-title":"LINC01355 contributes to Malignant phenotype of oral squamous cell carcinoma and cytotoxic T cell infiltration via activating notch signaling pathway","volume":"2021","author":"Zou","year":"2021","journal-title":"J Immunol Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2040768","article-title":"Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311\/GNG7 axis","volume":"13","author":"Zou","year":"2022","journal-title":"Bioengineered"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.7518\/hxkq.2021.06.006","article-title":"Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma","volume":"39","author":"Gao","year":"2021","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5625","article-title":"Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses Malignant progression of oral squamous cell carcinoma via miR-17-5p\/SOCS6 axis","volume":"53","author":"Du","year":"2023","journal-title":"Turk J Med Sci"},{"key":"B149","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14715\/cmb\/2024.70.9.14","article-title":"LncRNA PCBP1-AS1 suppresses cell growth in oral squamous cell carcinoma by targeting miR-34c-5p\/ZFP36 axis","volume":"70","author":"Shafiee Allaf","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/2211-5463.13532","article-title":"Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3","volume":"13","author":"Hu","year":"2023","journal-title":"FEBS Open Bio"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.624752","article-title":"Down-regulation of long non-coding RNA TINCR induces cell dedifferentiation and predicts progression in oral squamous cell carcinoma","volume":"10","author":"Zhuang","year":"2020","journal-title":"Front Oncol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/jop.13425","article-title":"LINC00173 blocks GATA6-mediated transcription of COL5A1 to affect Malignant development of oral squamous cell carcinoma","volume":"52","author":"Dong","year":"2023","journal-title":"J Oral Pathol Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.842960","article-title":"Novel angiogenic regulators and anti-angiogenesis drugs targeting angiogenesis signaling pathways: perspectives for targeting angiogenesis in lung cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms25147576","article-title":"MEG3-mediated oral squamous-cell-carcinoma-derived exosomal miR-421 activates angiogenesis by targeting HS2ST1 in vascular endothelial cells","volume":"25","author":"Huang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12888","article-title":"LncRNA NR2F2-AS1 inhibits the progression of oral squamous cell carcinoma by mediating the miR-32-5p\/SEMA3A axis","volume":"40","author":"Qin","year":"2024","journal-title":"Kaohsiung J Med Sci"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.605884","article-title":"Exosomal LncRNA LBX1-AS1 Derived From RBPJ Overexpressed-Macrophages Inhibits Oral Squamous Cell Carcinoma Progress via miR-182-5p\/FOXO3","volume":"11","author":"Ai","year":"2021","journal-title":"Front Oncol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03053-w","article-title":"Restoring BARX2 in OSCC reverses partial EMT and suppresses metastasis through miR-186-5p\/miR-378a-3p-dependent SERPINE2 inhibition","volume":"43","author":"Sun","year":"2024","journal-title":"Oncogene"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155532","article-title":"Metastasis and cell proliferation inhibition by microRNAs and its potential therapeutic applications in OSCC: A systematic review","volume":"262","author":"Malekjafarian","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00647-8","article-title":"MicroRNA-182-5p modulates oral squamous cell carcinoma migration and invasion via targeting MTSS1 gene","volume":"26","author":"Guo","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820959404","article-title":"miR-146b functions as an oncogene in oral squamous cell carcinoma by targeting HBP1","volume":"19","author":"Li","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202005_21169","article-title":"MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt\/\u03b2-catenin signaling pathway","volume":"24","author":"Zheng","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15036","article-title":"MiR-210-3p-EphrinA3-PI3K\/AKT axis regulates the progression of oral cancer","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11213","article-title":"MicroRNA-140-5p inhibits the tumorigenesis of oral squamous cell carcinoma by targeting p21-activated kinase 4","volume":"44","author":"Peng","year":"2020","journal-title":"Cell Biol Int"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105663","article-title":"MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6","volume":"119","author":"Wang","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/cbm-191362","article-title":"MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression","volume":"29","author":"Zhou","year":"2020","journal-title":"Cancer biomark"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14794","article-title":"MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32\/AKT signalling pathway","volume":"24","author":"He","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12967-025-06910-8","article-title":"miR-107 modulates EMT progression of OSCC by targeting SNCG and inhibiting the ERK\/NF-\u03baB signaling pathways","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174820","article-title":"miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins","volume":"920","author":"Ou","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4149\/neo_2019_190306N191","article-title":"MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4","volume":"67","author":"Cui","year":"2020","journal-title":"Neoplasma"},{"key":"B170","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","article-title":"TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer","volume":"22","author":"Giarratana","year":"2024","journal-title":"J Transl Med"},{"key":"B171","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13287-020-1576-3","article-title":"MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-\u03b2 signaling pathway","volume":"11","author":"You","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3727\/096504019x15761480623959","article-title":"miRNA-101 targets TGF-\u03b2R1 to retard the progression of oral squamous cell carcinoma","volume":"28","author":"Wang","year":"2020","journal-title":"Oncol Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10020-021-00359-3","article-title":"CircRNAs and their regulatory roles in cancers","volume":"27","author":"Tao","year":"2021","journal-title":"Mol Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-024-02082-z","article-title":"Circular RNAs in tumor immunity and immunotherapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B175","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms241814194","article-title":"CircRNAs: A promising star for treatment and prognosis in oral squamous cell carcinoma","volume":"24","author":"Zhu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00715-0","article-title":"Circ_0058063 contributed to oral squamous cell carcinoma development by sponging miR-145 and regulating PI3K\/AKT pathway","volume":"65","author":"Zhou","year":"2023","journal-title":"Mol Biotechnol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.154058","article-title":"Circ_0005050 promotes the proliferation of oral squamous cell carcinoma and inhibits the apoptosis by activating JAK\/STAT3 signaling pathway","volume":"238","author":"Huang","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.12.012","article-title":"Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC)","volume":"589","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2585","article-title":"circFNDC3B accelerates vasculature formation and metastasis in oral squamous cell carcinoma","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2074106","article-title":"Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p\/acylgycerol kinase (AGK) axis","volume":"13","author":"Long","year":"2022","journal-title":"Bioengineered"},{"key":"B181","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10142-023-00973-w","article-title":"Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell Malignant behaviors and glycolysis in oral squamous cell carcinoma progression","volume":"23","author":"Hei","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.771","article-title":"Downregulation of circLPAR3 inhibits tumor progression and glycolysis by liberating miR-144-3p and upregulating LPCAT1 in oral squamous cell carcinoma","volume":"7","author":"Su","year":"2022","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14019","article-title":"Hsa_circ_0009128 mediates progression of oral squamous cell carcinoma by influencing MMP9","volume":"29","author":"Zhang","year":"2023","journal-title":"Oral Dis"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14387","article-title":"Circ-OMAC drives metastasis in oral squamous cell carcinoma","volume":"30","author":"Li","year":"2024","journal-title":"Oral Dis"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13163","article-title":"Circ-LRP6 mediates epithelial-mesenchymal transition and autophagy in oral squamous cell carcinomas","volume":"50","author":"Zhang","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1555002","article-title":"CircRNA: the potential biomarkers and therapeutic targets in oral squamous cell carcinoma (OSCC)","volume":"15","author":"Lv","year":"2025","journal-title":"Front Oncol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2023.07.047","article-title":"Circ_0049396 attenuates the progression of oral squamous cell carcinoma by miR-650 suppression to induce neurofilament heavy polypeptide enhancement","volume":"136","author":"Yuan","year":"2023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12957-021-02184-8","article-title":"Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p\/UNC13C axis","volume":"19","author":"Dong","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14687","article-title":"Targeting Circ-OCAC suppress oral squamous cell carcinoma progression","volume":"30","author":"Li","year":"2024","journal-title":"Oral Dis"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27442","article-title":"The role and mechanism of circ-BNC2 on the Malignant progression of oral squamous cell carcinoma","volume":"45","author":"Xia","year":"2023","journal-title":"Head Neck"},{"key":"B191","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1089\/cbr.2019.3371","article-title":"hsa_circ_0072387 suppresses proliferation, metastasis, and glycolysis of oral squamous cell carcinoma cells by downregulating miR-503-5p","volume":"36","author":"Han","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"key":"B192","doi-asserted-by":"publisher","first-page":"e24486","DOI":"10.1002\/jcla.24486","article-title":"circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p","volume":"36","author":"Dai","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B193","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13578-020-00424-0","article-title":"Emerging functions and clinical applications of exosomes in human oral diseases","volume":"10","author":"Peng","year":"2020","journal-title":"Cell Biosci"},{"key":"B196","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise","volume":"17","author":"Morel","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43556-023-00126-2","article-title":"Epigenetic regulation and therapeutic targets in the tumor microenvironment","volume":"4","author":"Xie","year":"2023","journal-title":"Mol Biomed"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s12672-025-02928-y","article-title":"Epigenetic agents, zebularine and valproic acid, inhibit the growth of the oral squamous cell carcinoma cell line HSC4 in vitro and in vivo","volume":"16","author":"Takahashi","year":"2025","journal-title":"Discov Oncol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"e0296565","DOI":"10.1371\/journal.pone.0296565","article-title":"Intronic miR-6741-3p targets the oncogene SRSF3: Implications for oral squamous cell carcinoma pathogenesis","volume":"19","author":"More","year":"2024","journal-title":"PLoS One"},{"key":"B200","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/biomedicines10040763","article-title":"Enhanced cytotoxic effects in human oral squamous cell carcinoma cells treated with combined methyltransferase inhibitors and histone deacetylase inhibitors","volume":"10","author":"Ushio","year":"2022","journal-title":"Biomedicines"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2025.105232","article-title":"Synergistic effects of 5-azacitidine and photodynamic therapy using spirulina platensis on cell death in CAL27 oral squamous cell carcinoma Cells: Synergistic Anticancer Effects of 5-Azacitidine and Spirulina-Based Photodynamic Therapy in Oral Squamous Cell Carcinoma Cells","volume":"56","author":"Ranjbar","year":"2025","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109113","article-title":"Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma","volume":"111","author":"Yang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.2174\/1568009622666220406104732","article-title":"Inhibitor of growth 4 (ING4) plays a tumor-repressing role in oral squamous cell carcinoma via nuclear factor kappa-B (NF-kB)\/DNA methyltransferase 1 (DNMT1) axis-mediated regulation of aldehyde dehydrogenase 1A2 (ALDH1A2)","volume":"22","author":"Cui","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"key":"B204","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1517\/13543784.2014.952368","article-title":"Histone deacetylase inhibitors in oral squamous cell carcinoma treatment","volume":"24","author":"Tasoulas","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9468","article-title":"HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression","volume":"16","author":"Ahn","year":"2018","journal-title":"Oncol Lett"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113351","article-title":"Trichodermin inhibits the growth of oral cancer through apoptosis-induced mitochondrial dysfunction and HDAC-2-mediated signaling","volume":"153","author":"Chen","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2017.2418","article-title":"Sodium phenylbutyrate inhibits tumor growth and the epithelial-mesenchymal transition of oral squamous cell carcinoma in vitro and in vivo","volume":"33","author":"Qian","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1111\/jop.13326","article-title":"Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma","volume":"51","author":"Tavares","year":"2022","journal-title":"J Oral Pathol Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115634","article-title":"HDAC6 inhibition attenuates RIPK1\/RIPK3\/MLKL signalling and improves anti-tumor immune response in oral cancer","volume":"167","author":"Mahale","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.33594\/000000126","article-title":"Enhancement of histone deacetylase inhibitor sensitivity in combination with cyclin-dependent kinase inhibition for the treatment of oral squamous cell carcinoma","volume":"53","author":"Zhao","year":"2019","journal-title":"Cell Physiol Biochem"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22045","article-title":"PX-12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro","volume":"84","author":"Akhlaq","year":"2023","journal-title":"Drug Dev Res"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.065","article-title":"HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications","volume":"97","author":"Bayat","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B213","article-title":"Oral squamous cell carcinoma cancer stem cells have different drug sensitive to pharmacological NF\u03baB and histone deacetylation inhibition","volume":"13","author":"Silva","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3907","article-title":"Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro","volume":"12","author":"Sang","year":"2016","journal-title":"Exp Ther Med"},{"key":"B215","doi-asserted-by":"publisher","first-page":"e2005709","DOI":"10.1002\/adma.202005709","article-title":"Engineered extracellular vesicles for cancer therapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv Mater"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189101","article-title":"Extracellular vesicles in cancer therapy: Roles, potential application, and challenges","volume":"1879","author":"Liu","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.616101","article-title":"Research progress and prospect of nanoplatforms for treatment of oral cancer","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B218","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ijms21041197","article-title":"Extracellular vesicles in oral squamous cell carcinoma and oral potentially Malignant disorders: A systematic review","volume":"21","author":"Yap","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125224","article-title":"Light-activated photosensitizer\/quercetin co-loaded extracellular vesicles for precise oral squamous cell carcinoma therapy","volume":"671","author":"Liu","year":"2025","journal-title":"Int J Pharm"},{"key":"B220","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/pharmaceutics16010033","article-title":"Synergistic phototherapy-molecular targeted therapy combined with tumor exosome nanoparticles for oral squamous cell carcinoma treatment","volume":"16","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c00674","article-title":"Tetrahedral-DNA-nanostructure-modified engineered extracellular vesicles enhance oral squamous cell carcinomas therapy by targeting GPX4","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S277324","article-title":"Antitumor activity of cabazitaxel and MSC-TRAIL derived extracellular vesicles in drug-resistant oral squamous cell carcinoma","volume":"12","author":"Qiu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B223","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1038\/s41598-021-85242-1","article-title":"Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression","volume":"11","author":"Kase","year":"2021","journal-title":"Sci Rep"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00213","article-title":"MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer","volume":"18","author":"Sayyed","year":"2021","journal-title":"Mol Pharm"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.11.009","article-title":"\u03b3\u03b4TDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma","volume":"14","author":"Li","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B226","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.devcel.2024.07.003","article-title":"Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors","volume":"59","author":"Toh","year":"2024","journal-title":"Dev Cell"},{"key":"B227","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41598-018-36855-6","article-title":"Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma","volume":"9","author":"Rosenberger","year":"2019","journal-title":"Sci Rep"},{"key":"B228","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13287-022-02764-9","article-title":"Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246","volume":"13","author":"Liu","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101613","article-title":"Exosome isolation and characterization for advanced diagnostic and therapeutic applications","volume":"31","author":"Mukerjee","year":"2025","journal-title":"Mater Today Bio"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101259","article-title":"Bioengineering extracellular vesicle cargo for optimal therapeutic efficiency","volume":"32","author":"Ren\u00e9","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47865","article-title":"Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy","volume":"10","author":"Tang","year":"2020","journal-title":"Theranostics"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188784","article-title":"Exosomes at the crossroad between therapeutic targets and therapy resistance in head and neck squamous cell carcinoma","volume":"1877","author":"Jangholi","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: An update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist Updat"},{"key":"B234","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","article-title":"Drug-tolerant persister cells in cancer: the cutting edges and future directions","volume":"20","author":"Pu","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.017","article-title":"Mechanism of drug tolerant persister cancer cells: the landscape and clinical implication for therapy","volume":"16","author":"Mikubo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1116805","article-title":"Epigenetic reprogramming in cancer: From diagnosis to treatment","volume":"11","author":"Costa","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.822745","article-title":"Interaction of ncRNA and epigenetic modifications in gastric cancer: focus on histone modification","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"B238","article-title":"Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma","volume":"15","author":"Lima","year":"2022","journal-title":"Int J Clin Exp Pathology"},{"key":"B239","doi-asserted-by":"publisher","first-page":"e31164","DOI":"10.1002\/jcp.31164","article-title":"Up-regulation of TNF-alpha\/NFkB\/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma","volume":"239","author":"de Castro","year":"2024","journal-title":"J Cell Physiol"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2015.1090063","article-title":"The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma","volume":"14","author":"Banelli","year":"2015","journal-title":"Cell Cycle"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0459-x","article-title":"miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer","volume":"38","author":"Sun","year":"2019","journal-title":"Oncogene"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.02.010","article-title":"LINC00665 induces acquired resistance to gefitinib through recruiting EZH2 and activating PI3K\/AKT pathway in NSCLC","volume":"16","author":"Liu","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B243","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41375-019-0497-6","article-title":"Loss of KDM6A confers drug resistance in acute myeloid leukemia","volume":"34","author":"Stief","year":"2020","journal-title":"Leukemia"},{"key":"B244","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-020-01682-z","article-title":"Histone methyltransferase and drug resistance in cancers","volume":"39","author":"Yang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B245","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B246","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12194","article-title":"The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential","volume":"41","author":"Meng","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17998","article-title":"Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages","volume":"27","author":"Wu","year":"2023","journal-title":"J Cell Mol Med"},{"key":"B248","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2020.11.046","article-title":"Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma","volume":"503","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"B249","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3892\/etm.2021.9839","article-title":"Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p\/TRIM14 axis","volume":"21","author":"Xiao","year":"2021","journal-title":"Exp Ther Med"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.64253","article-title":"Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA\/BCL2 mediated apoptosis in oral squamous cellular cancer","volume":"18","author":"Qiao","year":"2021","journal-title":"Int J Med Sci"},{"key":"B251","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-021-04497-8","article-title":"Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas","volume":"13","author":"Gao","year":"2022","journal-title":"Cell Death Dis"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31116","article-title":"circAP1M2 activates ATG9A-associated autophagy by inhibiting miR-1249-3p to promote cisplatin resistance in oral squamous cell carcinoma","volume":"238","author":"Wenhao","year":"2023","journal-title":"J Cell Physiol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.3928","article-title":"Circ_0109291 promotes cisplatin resistance of oral squamous cell carcinoma by sponging miR-188-3p to increase ABCB1 expression","volume":"37","author":"Gao","year":"2022","journal-title":"Cancer Biother Radiopharm"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmx078","article-title":"Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.120015","article-title":"Carcinoma-associated fibroblast-derived exosomes lncRNA RORA-AS1 facilitates radiotherapy resistance of oral squamous cell carcinoma through the IFITM1\/STAT axis","volume":"1872","author":"Li","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B256","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mog2.68","article-title":"Targets of tumor microenvironment for potential drug development","volume":"3","author":"Zhang","year":"2024","journal-title":"Medcomm-Oncology"},{"key":"B257","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B259","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/17501911.2024.2430169","article-title":"Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities","volume":"17","author":"Vatapalli","year":"2025","journal-title":"Epigenomics"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1758433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:11:57Z","timestamp":1771924317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1758433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":259,"alternative-id":["10.3389\/fimmu.2026.1758433"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1758433","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"article-number":"1758433"}}